FDLI Commitment to Diversity & Inclusion
FDLI Policy for Commitment to Diversity and Inclusion
As a membership organization, FDLI is committed to supporting, promoting, and celebrating diversity, equity and inclusion in the food and drug law profession. In order to fulfill this key aspect of our mission and core values as an organization, the FDLI Board of Directors affirms that all members and professionals within the field, whatever their race, religion, ethnicity, gender, gender identity or expression, national origin, genetics, age, sexual orientation, or disability, are valued, respected, and included in our community. We seek to address inequities not only within FDLI’s organizational positions, including member committee leadership/membership, speaking and author roles, and staff, but also in the pipeline of emerging food and drug law professionals in our work with graduate schools, law schools, and students.
Adopted by the FDLI Board of Directors, Sept. 9, 2020.
Diversity, Equity, and Inclusion Advisory Committee
Benjamin Butz (Staff Liaison), FDLI
Elizabeth “Betsy” Anderson, Anderson & Associates, LLC and Anthony Lee, Blacks in Government (BIG)
Oluwaseun (Kemi) Asante, FDA – CDER
Kenita Barrow, Otsuka America Pharmaceutical, Inc.
L’Tonya Davis, FDA – ORA
Kristin M. Kaplan, Shook, Hardy & Bacon LLP
Daniel Kracov, Arnold & Porter LLP
Sarah Schick, DLA Piper LLP (US)
John (Barr) Weiner, FDA – OC